Osaka, Japan

Kouichi Iwanaga

This inventor holds 13 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Takeda Pharmaceutical Company Limited, Matsushita Electric Works, Ltd.. Active years: 1981-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kouichi Iwanaga. Retrieved from https://idiyas.com/inventor/kouichi-iwanaga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 84.6

 

 

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 181(Granted Patents)


Location History:

  • Hikone, JP (1981 - 1989)
  • Kanagawa i, JP (2014)
  • Osaka, JP (1984 - 2015)
  • Kanagawa, JP (2016)
  • Fujisawa, JP (2020 - 2023)

Company Filing History:


Years Active: 1981-2026

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: **Kouichi Iwanaga: Innovator in Pharmaceutical Chemistry**

Introduction

Kouichi Iwanaga, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of 12 patents, Iwanaga has focused his research on developing innovative compounds that target various medical conditions, enhancing treatment options for patients around the world.

Latest Patents

Among his latest inventions, Iwanaga has developed a heterocyclic compound with potential therapeutic applications. This compound exhibits antagonistic action on an NMDA receptor containing the NR2B subunit. It is expected to be beneficial in the prophylaxis and treatment of major depression, bipolar disorder, migraine, pain, and behavioral and psychological symptoms associated with dementia. The compound, represented by a specific formula, highlights Iwanaga's commitment to advancing medical science and addressing pressing health challenges.

Career Highlights

Kouichi Iwanaga has held influential positions at notable companies, including Takeda Pharmaceutical Company Limited and Matsushita Electric Works, Ltd. His expertise and innovative mindset have allowed him to contribute meaningfully to advancements in pharmaceuticals, particularly in the development of compounds with substantial therapeutic benefits.

Collaborations

Throughout his career, Iwanaga has collaborated with esteemed colleagues such as Takanobu Kuroita and Yasuhiro Imaeda. These partnerships have facilitated the exchange of ideas and techniques, fostering an environment rich in innovation and creativity.

Conclusion

Kouichi Iwanaga's groundbreaking work in the realm of heterocyclic compounds underscores the vital role of inventors in the pharmaceutical industry. His patents not only reflect his ingenuity but also promise to significantly impact treatments for various medical conditions, paving the way for future innovations in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…